DZ2516A1 - Composition pharmaceutique en aérosol. - Google Patents

Composition pharmaceutique en aérosol.

Info

Publication number
DZ2516A1
DZ2516A1 DZ980126A DZ980126A DZ2516A1 DZ 2516 A1 DZ2516 A1 DZ 2516A1 DZ 980126 A DZ980126 A DZ 980126A DZ 980126 A DZ980126 A DZ 980126A DZ 2516 A1 DZ2516 A1 DZ 2516A1
Authority
DZ
Algeria
Prior art keywords
pharmaceutical composition
aerosol pharmaceutical
aerosol
composition
pharmaceutical
Prior art date
Application number
DZ980126A
Other languages
English (en)
Inventor
David Lewis
Davis Canderton
Brian Meakin
Paolo Ventura
Gaetano Brambilla
Raffaella Garzia
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ2516(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of DZ2516A1 publication Critical patent/DZ2516A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
DZ980126A 1997-06-13 1998-06-13 Composition pharmaceutique en aérosol. DZ2516A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions

Publications (1)

Publication Number Publication Date
DZ2516A1 true DZ2516A1 (fr) 2004-11-08

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980126A DZ2516A1 (fr) 1997-06-13 1998-06-13 Composition pharmaceutique en aérosol.

Country Status (45)

Country Link
EP (2) EP0920302B2 (fr)
JP (1) JP4380802B2 (fr)
KR (1) KR100546239B1 (fr)
CN (1) CN1138532C (fr)
AR (1) AR012977A1 (fr)
AT (1) ATE222751T1 (fr)
AU (1) AU729966B2 (fr)
BG (1) BG63906B1 (fr)
BR (1) BR9805993B1 (fr)
CA (1) CA2263445C (fr)
CO (1) CO4940408A1 (fr)
CZ (1) CZ295521B6 (fr)
DE (1) DE69807420T3 (fr)
DK (1) DK0920302T4 (fr)
DZ (1) DZ2516A1 (fr)
EA (1) EA001259B1 (fr)
EE (1) EE03664B1 (fr)
ES (1) ES2182351T5 (fr)
GB (1) GB2326334A (fr)
GE (1) GEP20012462B (fr)
HK (1) HK1022271A1 (fr)
HR (1) HRP980317B1 (fr)
HU (1) HU228487B1 (fr)
ID (1) ID21491A (fr)
IL (1) IL128484A (fr)
IN (1) IN189317B (fr)
IS (1) IS2435B (fr)
IT (1) IT1293803B1 (fr)
MA (1) MA26507A1 (fr)
ME (2) ME00333B (fr)
MY (1) MY119074A (fr)
NO (1) NO327775B1 (fr)
NZ (1) NZ334149A (fr)
PL (1) PL193721B1 (fr)
PT (1) PT920302E (fr)
RS (1) RS51274B (fr)
SA (1) SA98190821B1 (fr)
SI (1) SI0920302T2 (fr)
SK (1) SK284430B6 (fr)
TN (1) TNSN98087A1 (fr)
TR (1) TR199900288T1 (fr)
TW (1) TW555570B (fr)
UA (1) UA70289C2 (fr)
WO (1) WO1998056349A1 (fr)
ZA (1) ZA985136B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
US6479035B1 (en) 1999-09-11 2002-11-12 Smithkline Beecham Corporation Pharmaceutical formulation of fluticasone propionate
EP1231894B1 (fr) * 1999-11-23 2005-01-12 Glaxo Group Limited Formulations pharmaceutiques de salmeterol
DE60019167T2 (de) * 1999-12-24 2006-05-11 Glaxo Group Ltd., Greenford Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
CZ303833B6 (cs) * 2000-05-22 2013-05-22 Chiesi Farmaceutici S.P.A. Aerosolový prostredek
AU2002238748A1 (en) * 2001-03-12 2002-09-24 Glaxo Group Limited Pharmaceutical aerosol formulation
TR200401980T4 (tr) 2001-07-02 2004-09-21 Chiesi Farmaceutici S.P.A. Aerosol olarak uygulama için en uygun hale getirilmiş tobramisin formülasyonu
EP1340503A1 (fr) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Formule d'une solution pour aerosol contenant des dérivés d'esters de 3,17 estratrien pour administration pulmonale
EP1340492A1 (fr) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Formulations d'aérosol pour l'administration par voie pulmonaire de medicaments avec effet systémique
ES2779273T3 (es) 2002-03-01 2020-08-14 Chiesi Farm Spa Formulación superfina de formoterol
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
DE60216242T2 (de) * 2002-06-06 2007-05-24 Chiesi Farmaceutici S.P.A. Lösung von Wirkstoffen in HFA-Treibgasen mittels Emulsionen
WO2004071488A1 (fr) * 2003-02-04 2004-08-26 Chrysalis Technologies Incorporated Preparations de perfluorocarbure et d'hydrofluorocarbure et procedes de fabrication et d'utilisation de celles-ci
AU2004224367B2 (en) * 2003-03-20 2009-10-08 Boehringer Ingelheim Pharmaceuticals, Inc. Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants
EP1915985A1 (fr) 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation pour une dose mesurée utilisant des hydro-fluoro-alcanes en tant que propulseurs
EP1595531A1 (fr) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Formulation d'une solution pharmaceutique stable pour aérosols doseurs sous pression
EA013428B1 (ru) 2004-07-02 2010-04-30 Бёрингер Ингельхайм Интернациональ Гмбх РАСПЫЛЯЕМЫЕ В ВИДЕ АЭРОЗОЛЯ СУСПЕНЗИОННЫЕ КОМПОЗИЦИИ С TG 227ea ИЛИ TG 134a В КАЧЕСТВЕ ПРОПЕЛЛЕНТА
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
EP2217278A1 (fr) * 2007-11-07 2010-08-18 AstraZeneca AB Formulations de poudre sèche comportant des dérivés de l'acide ascorbique
CN105854136A (zh) * 2010-09-06 2016-08-17 奇斯药制品公司 计量剂量吸入器和使用该计量剂量吸入器的方法
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
EP2819669B1 (fr) 2012-02-28 2021-04-21 Boehringer Ingelheim International GmbH Nouvelle formulation de tiotropium contenant un gaz propulseur
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
WO2016018892A1 (fr) 2014-07-29 2016-02-04 3M Innovative Properties Company Procédé de préparation d'une composition pharmaceutique
WO2017167737A1 (fr) 2016-03-31 2017-10-05 Chiesi Farmaceutici S.P.A. Dispositif d'inhalation d'aérosol
EA201990501A1 (ru) * 2016-09-19 2019-09-30 Мехикем Флуор С.А. Де С.В. Фармацевтическая композиция

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005211A1 (fr) † 1986-03-10 1987-09-11 Kurt Burghart Preparation pharmaceutique et son procede de production
EP0259383B1 (fr) † 1986-03-10 1991-01-23 Kurt Dr. Burghart Produit pharmaceutique et son procede de preparation
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
DK0553298T3 (da) † 1990-10-18 1995-04-18 Minnesota Mining & Mfg Aerosolformulering omfattende beclomethason-17,21-dipropionat
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
ES2269582T3 (es) † 1991-06-10 2007-04-01 Schering Corporation Formulaciones en aerosol sin clorofluorocarbonos.
DE69231992T2 (de) † 1991-06-10 2001-12-13 Schering Corp Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
DE69205177T2 (de) * 1991-12-12 1996-03-21 Glaxo Group Ltd Pharmazeutische Aerosolformulierung.
DK0617610T3 (da) * 1991-12-18 1997-10-06 Minnesota Mining & Mfg Suspensionsaerosolformuleringer.
EP0673240B1 (fr) * 1992-12-09 1999-03-24 Boehringer Ingelheim Pharmaceuticals Inc. Formulations de solutions medicinales aerosol stabilisees
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
JP3911290B2 (ja) † 1994-05-13 2007-05-09 アラダイム コーポレーション エアゾールを含む麻酔用処方
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
EP0914143A1 (fr) * 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Formulation d'une solution d'aerosol medicinal de cyclosporine a
WO1998024420A1 (fr) † 1996-12-04 1998-06-11 Bioglan Ireland (R & D) Limited Compositions pharmaceutiques et leurs dispositifs d'administration
JP2001511160A (ja) † 1997-02-05 2001-08-07 ヤゴ リサーチ アクチェンゲゼルシャフト 医学用エアゾール配合物

Also Published As

Publication number Publication date
CA2263445C (fr) 2008-09-09
PL193721B1 (pl) 2007-03-30
ID21491A (id) 1999-06-17
GB2326334A (en) 1998-12-23
ME00333B (me) 2011-02-10
CZ295521B6 (cs) 2005-08-17
PT920302E (pt) 2002-11-29
CA2263445A1 (fr) 1998-12-17
NZ334149A (en) 2000-07-28
KR100546239B1 (ko) 2006-01-26
DE69807420D1 (de) 2002-10-02
IT1293803B1 (it) 1999-03-10
YU6999A (sh) 2000-03-21
HRP980317B1 (en) 2002-06-30
DK0920302T3 (da) 2002-12-23
NO990594D0 (no) 1999-02-09
IL128484A (en) 2004-09-27
CN1138532C (zh) 2004-02-18
EP0920302B1 (fr) 2002-08-28
GB9712434D0 (en) 1997-08-13
EP0920302B2 (fr) 2006-06-21
IS4974A (is) 1999-02-11
ZA985136B (en) 1999-01-07
AU729966B2 (en) 2001-02-15
UA70289C2 (uk) 2004-10-15
NO327775B1 (no) 2009-09-21
SI0920302T1 (en) 2002-12-31
BG103221A (en) 1999-09-30
TW555570B (en) 2003-10-01
CZ46299A3 (cs) 1999-07-14
BR9805993A (pt) 1999-08-31
ES2182351T3 (es) 2003-03-01
HK1022271A1 (en) 2000-08-04
EA001259B1 (ru) 2000-12-25
BG63906B1 (bg) 2003-06-30
TNSN98087A1 (fr) 2005-03-15
HU228487B1 (en) 2013-03-28
DE69807420T2 (de) 2003-05-08
GEP20012462B (en) 2001-06-25
SI0920302T2 (sl) 2006-10-31
IN189317B (fr) 2003-02-08
EP0920302A1 (fr) 1999-06-09
MY119074A (en) 2005-03-31
EE03664B1 (et) 2002-04-15
HUP0001339A3 (en) 2000-10-30
SK284430B6 (sk) 2005-04-01
HUP0001339A2 (hu) 2000-09-28
IL128484A0 (en) 2000-01-31
RS51274B (sr) 2010-12-31
DK0920302T4 (da) 2006-10-09
HRP980317A2 (en) 1999-04-30
SK17699A3 (en) 1999-07-12
MA26507A1 (fr) 2004-12-20
WO1998056349A1 (fr) 1998-12-17
EE9900055A (et) 1999-08-16
EP1219293A3 (fr) 2003-05-28
ITMI971798A1 (it) 1999-01-28
ATE222751T1 (de) 2002-09-15
IS2435B (is) 2008-10-15
MEP44008A (en) 2011-02-10
NO990594L (no) 1999-04-13
AR012977A1 (es) 2000-11-22
DE69807420T3 (de) 2006-11-16
CO4940408A1 (es) 2000-07-24
BR9805993B1 (pt) 2009-05-05
AU8626298A (en) 1998-12-30
EA199900201A1 (ru) 1999-06-24
JP2000516965A (ja) 2000-12-19
EP1219293A2 (fr) 2002-07-03
PL331531A1 (en) 1999-07-19
CN1229355A (zh) 1999-09-22
TR199900288T1 (xx) 1999-09-21
JP4380802B2 (ja) 2009-12-09
ES2182351T5 (es) 2007-03-16
KR20000068171A (ko) 2000-11-25
SA98190821B1 (ar) 2006-11-19

Similar Documents

Publication Publication Date Title
DZ2516A1 (fr) Composition pharmaceutique en aérosol.
DE69530325D1 (de) Aerosol-arzneiformulierungen
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
DK1073417T3 (da) Farmaceutisk aerosolformulering
HK1027957A1 (en) Pharmaceutical composition.
ZA989680B (en) Pharmaceutical composition.
DZ3164A1 (fr) Nouvel agent pharmaceutique.
EE9900545A (et) Farmatseutiline kompositsioon
MA26531A1 (fr) Composition pharmaceutique
ID29294A (id) Komposisi farmasi
TR199501082A2 (tr) Farmasötik formülasyonlar.
ID25857A (id) Komposisi farmasi
DZ1965A1 (fr) Composition pharmaceutique nouvelle.
ID23531A (id) Komposisi farmasi
DK1037604T3 (da) Farmaceutiske aerosolsammensætninger
TR199500776A2 (tr) Farmasötik bilesimler.
BR1100755A (pt) composição farmacêutica
FR2721515B1 (fr) Composition pharmaceutique antibactérienne.
FI3163U1 (fi) Lääkesäiliö
BR1100782A (pt) Fenilimidazolidinas substituìdas, sua aplicação como medicamentos e as composições farmacêuticas que as contêm
ID21180A (id) Senyawa-senyawa farmasi